427 related articles for article (PubMed ID: 17561877)
21. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
22. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas.
Martini M; Capello D; Serraino D; Navarra A; Pierconti F; Cenci T; Gaidano G; Larocca LM
J Infect; 2007 Mar; 54(3):298-306. PubMed ID: 16784778
[TBL] [Abstract][Full Text] [Related]
23. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma.
Van Baarle D; Wolthers KC; Hovenkamp E; Niesters HG; Osterhaus AD; Miedema F; Van Oers MH
J Infect Dis; 2002 Aug; 186(3):405-9. PubMed ID: 12134237
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma.
Jo SA; Hwang SH; Kim SY; Shin HJ; Chung JS; Sol MY; Chang CL; Lee EY
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e106-13. PubMed ID: 19522857
[TBL] [Abstract][Full Text] [Related]
25. Primary Epstein-Barr virus infection with neurological complications.
Bathoorn E; Vlaminckx BJ; Schoondermark-Stolk S; Donders R; van der Meulen M; Thijsen SF
Scand J Infect Dis; 2011 Feb; 43(2):136-44. PubMed ID: 21070089
[TBL] [Abstract][Full Text] [Related]
26. EBV detection in HIV-related oral plasmablastic lymphoma.
Ferrazzo KL; Mesquita RA; Aburad AT; Nunes FD; de Sousa SO
Oral Dis; 2007 Nov; 13(6):564-9. PubMed ID: 17944673
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus in Hodgkin's disease from patients with human immunodeficiency virus infection.
Moran CA; Tuur S; Angritt P; Reid AH; O'Leary TJ
Mod Pathol; 1992 Jan; 5(1):85-8. PubMed ID: 1311840
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infection.
Willoughby CE; Baker K; Kaye SB; Carey P; O'Donnell N; Field A; Longman L; Bucknall R; Hart CA
J Med Virol; 2002 Nov; 68(3):378-83. PubMed ID: 12226825
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction.
Kullberg-Lindh C; Ascher H; Saalman R; Olausson M; Lindh M
Pediatr Transplant; 2006 Feb; 10(1):83-9. PubMed ID: 16499593
[TBL] [Abstract][Full Text] [Related]
30. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
31. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease.
Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D
J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein-Barr viraemia.
Martelius T; Lappalainen M; Aalto SM; Nihtinen A; Hedman K; Anttila VJ
Clin Microbiol Infect; 2010 Jun; 16(6):657-62. PubMed ID: 19694766
[TBL] [Abstract][Full Text] [Related]
33. Host-Epstein-Barr virus relationship affected by immunostimulation in HIV-infected patients representing distinct progressor profile groups.
Friis AM; Åkerlund B; Gyllensten K; Aleman A; Ernberg I
Scand J Infect Dis; 2012 May; 44(5):388-92. PubMed ID: 22243136
[TBL] [Abstract][Full Text] [Related]
34. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
35. Quantitative tissue polymerase chain reaction for Epstein-Barr virus in pediatric solid organ recipients.
Gupta M; Filler G; Kovesi T; Shaw L; Forget C; Carpenter B; Reisman J; Feber J; Diaz-Mitoma F
Am J Kidney Dis; 2003 Jan; 41(1):212-9. PubMed ID: 12500239
[TBL] [Abstract][Full Text] [Related]
36. Aggressive forms of non-Hodgkin's lymphoma in two patients bearing coinfection of Epstein-Barr and hepatitis C viruses.
Libra M; Gloghini A; De Re V; Rupolo M; Navolanic PM; Gasparotto D; Stivala F; Spina M; Boiocchi M; Carbone A
Int J Oncol; 2005 Apr; 26(4):945-50. PubMed ID: 15753988
[TBL] [Abstract][Full Text] [Related]
37. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
Liu JR; Lin Q; Wu XY
Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
[TBL] [Abstract][Full Text] [Related]
38. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
Ahya VN; Douglas LP; Andreadis C; Arnoldi S; Svoboda J; Kotloff RM; Hadjiliadis D; Sager JS; Woo YJ; Pochettino A; Schuster SJ; Stadtmauer EA; Tsai DE
J Heart Lung Transplant; 2007 Aug; 26(8):839-44. PubMed ID: 17692789
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system.
Volpi A
Herpes; 2004 Jun; 11 Suppl 2():120A-127A. PubMed ID: 15319099
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
